Cadila Healthcare Limited Stock NSE India S.E.
Equities
INE010B01019
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- INR | - |
Sales 2024 * | 193B 2.31B | Sales 2025 * | 210B 2.52B | Capitalization | 943B 11.29B |
---|---|---|---|---|---|
Net income 2024 * | 35.72B 428M | Net income 2025 * | 37.31B 447M | EV / Sales 2024 * | 4.82 x |
Net cash position 2024 * | 14.67B 176M | Net cash position 2025 * | 35.75B 428M | EV / Sales 2025 * | 4.32 x |
P/E ratio 2024 * |
26.2
x | P/E ratio 2025 * |
25.1
x | Employees | - |
Yield 2024 * |
0.62% | Yield 2025 * |
0.62% | Free-Float | 24.87% |
Latest transcript on Cadila Healthcare Limited
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | 97-07-31 | |
Director of Finance/CFO | - | - | |
Chairman | 71 | 95-05-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 18-12-05 | |
Chairman | 71 | 95-05-14 | |
Director/Board Member | 69 | 97-07-31 |
1st Jan change | Capi. | |
---|---|---|
+19.84% | 43.54B | |
+16.96% | 21.74B | |
+8.52% | 13.02B | |
+6.06% | 13.53B | |
-11.05% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.71% | 5.09B | |
+3.49% | 4.42B |